Actively Recruiting

Age: 10Years - 15Years
All Genders
NCT02434003

Prospective Multicenter Evaluation of a New Predictive Model for the Progression of Adolescent Idiopathic Scoliosis

Led by St. Justine's Hospital · Updated on 2024-04-17

1200

Participants Needed

9

Research Sites

708 weeks

Total Duration

On this page

Sponsors

S

St. Justine's Hospital

Lead Sponsor

Q

Queen Mary Hospital, Hong Kong

Collaborating Sponsor

AI-Summary

What this Trial Is About

Scoliosis is a three-dimensional deformity affecting the orientation and position of the spine. Locally, the shape of the vertebra is also affected. The most common form is adolescent idiopathic scoliosis (AIS) with a prevalence of 1-3% affecting primarily young adolescent females. AIS can either be treated using a brace and in some cases necessitate surgical correction to prevent progressive deformity. Risk factors for progression include female gender, curve magnitude and location, skeletal maturity and growth velocity. However, these risk factors have been shown to be inconsistent in predicting curve progression. Over the past 6 years, the investigators have developed a predictive model of the final Cobb angle in AIS based on 3D spinal parameters. This analysis was based on a prospective cohort of 195 patients that were enrolled upon their initial visit and followed until maturity. This predictive model has a determination coefficient of 0.702. The proposed new study aims at refining and testing the external validity of this model in a larger cohort. The next step towards using the new model in the clinical setting is to redesign the model and to externally validate the model by measuring the agreement between the new method and the traditional Cobb angle at maturity in a larger multicenter study. The objective of this study is to characterize the risk of scoliosis progression based on local three-dimensional vertebral and pelvic measurements present on initial evaluation. Three-dimensional reconstructions will be derived from stereo-radiographs acquired with a new biplanar low-dose radiographic system installed in all 8 clinical sites (EOS system, EOS-Imaging, Paris). These calibrated radiographs will then be used to reconstruct the vertebrae and intervertebral disks at each level as well as the geometry of the pelvis. A series of local and regional parameters will then be calculated from these 3D reconstructions. Correlation analysis will help determine if intervertebral disk wedging, vertebral wedging, transverse plane rotation or pelvic geometry can be used as early predictors of curve progression in AIS. Identifying a new 3D measure of scoliosis associated with rapid curve progression could help predict which curves need early treatment to prevent further progression. The ultimate goal of this research project will be to validate this new predictive model and finally transfer this new predictive tool in the hands of clinicians treating AIS.

CONDITIONS

Official Title

Prospective Multicenter Evaluation of a New Predictive Model for the Progression of Adolescent Idiopathic Scoliosis

Who Can Participate

Age: 10Years - 15Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosed with idiopathic scoliosis by a surgeon
  • Age above 10 years at recruitment
  • Spina bifida occulta without neurological signs and otherwise normal
  • Cobb angle between 11 and 40 degrees
  • Risser sign of 0 or 1 on a standing postero-anterior digital spine X-ray
  • Includes single thoracic, thoraco-lumbar, lumbar, double major, and triple major curves
Not Eligible

You will not qualify if you...

  • Previous surgery on thoracic spine, pelvis, or spine
  • Congenital scoliosis
  • MRI abnormalities including syrinx larger than 4mm or Chiari malformation
  • Syndromic scoliosis such as Marfan's or other genetic syndromes
  • Neuromuscular scoliosis
  • Developmental delay
  • Spinal asymmetry
  • Symptomatic spondylolisthesis
  • Leg length difference greater than 1 cm
  • Unable or unwilling to commit to required follow-up visits

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 9 locations

1

Rady Children's Hospital

San Diego, California, United States, 92123

Actively Recruiting

2

Alfred I. duPont Hospital for Children

Wilmington, Delaware, United States, 19803

Not Yet Recruiting

3

Miami Children's Hospital

Miami, Florida, United States, 33155

Not Yet Recruiting

4

Mayo Clinic

Minneota, Minnesota, United States, MN 55902

Not Yet Recruiting

5

St Justine's Hospital

Montreal, Quebec, Canada, H3T 1C4

Actively Recruiting

6

Robert Debré Hospital

Paris, France, 75019

Not Yet Recruiting

7

Queen Mary Hospital

Hong Kong, Hong Kong

Actively Recruiting

8

The Meijo Hospital

Nagoya, Japan

Actively Recruiting

9

National University

Singapore, Singapore

Not Yet Recruiting

Loading map...

Research Team

S

Stefan Parent, MD, PhD

CONTACT

M

Marjolaine Roy-Beaudry

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here